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Abstract
Background Zebrafish are growing in use as a model for understanding drug dependence and addiction. Sensitization para-
digms have been a useful tool in identifying mechanisms involved in drug-induced behavioral and neurological changes, but 
in zebrafish have tended to focus on locomotor, rather than cognitive, endpoints.
Methods Here, we used a novel method, the FMP Y-maze, which measures continuous performance through a series of 
repeated binary choices (L vs R), to establish a model for assessing parameters associated with psychostimulant-induced 
behavioral and cognitive sensitization in adult zebrafish.
Results Repeat, intermittent exposure to d-amphetamine (AMPH) for 14 days increased alternations (LRLR) in the maze, 
suggesting improved working memory, which was enhanced further following drug challenge after a short withdrawal 
period, suggesting behavioral sensitization. However, this cognitive enhancement coincided with a reduction in the use of 
other exploration strategies, hypolocomotion, and inhibition of cognitive flexibility. Like AMPH, exposure to nicotine (NIC) 
increased alternations following drug challenge after chronic treatment. Repeat NIC exposure appeared to induce both cogni-
tive and psychomotor sensitization, as evidenced by increased working memory performance (alternations) and locomotor 
activity, without negatively impacting other search strategies or cognitive flexibility.
Conclusion Chronic treatment with AMPH or NIC boosts cognitive performance in adult zebrafish. Cognitive sensitization 
occurred with both drugs, resulting in enhanced working memory; however, repeat AMPH exposure, following a withdrawal 
period, resulted in inhibited cognitive flexibility, an effect not evident with repeat NIC exposure. Cognitive and behavioral 
sensitization paradigms in zebrafish could serve as a useful tool for assessing cognitive states which result in cognitive 
enhancing or impairing effects of drugs.
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Introduction
Psychostimulants, such as amphetamine (AMPH), nicotine 
(NIC), and cocaine, are known to increase extracellular 
synaptic dopamine (DA) concentrations and activate DA 
neurotransmission, resulting in altered behavioral and loco-
motor responses (Brown and Kolb 2001; Cunningham et al. 
1997; Dela Peña et al. 2015; Di Chiara and Bassareo 2007; 
Niculescu et al. 2005; Volkow et al. 1999). Repeated admin-
istration of a psychostimulant drug enhances psychomotor 
responsiveness to the drug. This is mediated by enhance-
ment of dopaminergic activation and modification of den-
dritic morphology, which can last for extended periods 
(Robinson and Berridge 1993). This long-term ability of 
previously encountered drugs to activate DA neurotrans-
mission and modify behavioral outputs is known as drug-
induced sensitization. Sensitization to repeated, intermit-
tent drug exposure in humans is theorized to be a critical 
driver in maintaining drug use and escalation from casual 
experimentation to craving and abuse. Furthermore, those 
attempting to withdraw from their habit can relapse fol-
lowing long periods of abstinence (Robinson and Berridge 
2008; Vezina 2007). The psychostimulants AMPH and 
NIC have been well documented for modulating locomotor 
responses (Buenrostro-Jáuregui et al. 2016; Cunningham 
et al. 1997; Pisera-Fuster et al. 2019; Valjent et al. 2010), as 
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well as cognitive altering effects in both animals and humans 
(Kuhn et al. 2019; Steketee and Kalivas 2011; Vezina 2007; 
Vezina and Leyton 2009). Expanding our understanding 
of the mechanisms underlying drug-induced sensitization 
may boost the efficiency of therapies used to treat substance 
abuse and reduce the probability of relapse.
Conservation of the ascending midbrain dopaminer-
gic pathways between mammals and teleost fish, such as 
zebrafish, has resulted in the increasing use of zebrafish 
as a neurobehavioral model for assessing the effects of 
pharmaceutical and illicit drugs (Antunes and Biala 2012; 
Barros et al. 2008; Goldsmith 2004; Kalueff et al. 2014). 
Behavioral responses of zebrafish to psychostimulant drug 
exposure (e.g. amphetamine (Parker et al. 2012), cocaine 
(Lopez Patino et al. 2008), or nicotine (Suen et al. 2013)) 
have corroborated findings in rodents and humans, thus sup-
porting the suitability of zebrafish as a translational model of 
psychostimulant abuse (Parker and Brennan 2012; Stewart 
et al. 2015). There have been several studies that have dem-
onstrated drug-induced sensitization in zebrafish (Blaser et al. 
2010; Pisera-Fuster et al. 2019). Although these studies have 
been a useful starting point, they have yet to further our under-
standing of the mechanisms underpinning sensitization, and 
the relationship between sensitization, addiction, and relapse. 
In addition, despite extensive investigation into psychomotor 
sensitization, few studies have investigated the role of cognitive 
sensitization (Castner and Goldman-Rakic 2004; Muhammad 
and Kolb 2011; Peleg-Raibstein et al. 2009) and none, to our 
knowledge, has done so in zebrafish.
Here, we aimed to establish  whether young-adult 
zebrafish develop cognitive or psychomotor sensitization to 
repeated administrations of AMPH and NIC, as assessed 
through the impact on working memory, locomotor activity, 
and cognitive flexibility. To do this, we used an established 
behavioral assay for zebrafish that has high translational rel-
evance to humans, the FMP Y-maze (Cleal et al. 2020). We 
assessed locomotor activity, working memory, and behavio-
ral flexibility at four time points: baseline (prior to any drug 
exposure), chronic exposure (14 days of drug exposure), 
withdrawal (2 days without drug), and finally following 
drug challenge (single, repeat drug exposure). Changes in 
cognitive performance and motor activity were determined 
relative to baseline, pre-drug exposure levels. To our knowl-
edge, this is the first study to examine the cognitive effects 
of psychostimulant sensitization in zebrafish.
Materials and methods
Subjects and drugs
Thirty-six adult, AB wild-type, mixed sex (50:50 M:F) 
zebrafish (Danio rerio), aged 3 months old at the start of 
treatment, were used for this study. Sample size (N = 36 
(n = 12/treatment group) [50:50 M:F]) was determined by 
power analyses based on large effect sizes (f2 > 0.3) observed 
in extensive previous experiments in our group using the 
FMP Y-maze. Housing conditions were maintained on a 
re-circulating system (Aquaneering Inc., San Diego, CA, 
USA); tank water was maintained at pH 8.4 (± 0.4), tem-
perature 25–27 °C, on a 14-h:10-h light/dark cycle. From 
free-feeding (5 days post fertilization (dpf)), fish were fed on 
ZM fry food until adulthood when they were fed on a daily 
diet of live brine shrimp (maintained at the fish facility) and 
dried flake food (ZM Systems, UK) 3 times/day during the 
week and once/day at weekends. All fish used in this study 
were experimentally naïve. Ethical approval was granted by 
the University of Portsmouth Animal Welfare and Ethical 
Review Board and conducted in accordance to the Animals 
(Scientific Procedures) Act 1986. Drugs were obtained from 
Sigma-Aldrich (Dorset, UK). Drug solutions were made up 
in aquarium water at pH 8–9. Moderate doses of AMPH and 
NIC were based on previous studies which found these con-
centrations to have reinforcing effects on zebrafish, assessed 
in the conditioned placed preference (CPP) task (Brock et al. 
2017; Kalueff 2017; Kily et al. 2008; Ninkovic and Bally-
Cuif 2006; Parker et al. 2013a, b). All experiments were 
carried out in line with ARRIVE guidelines (NC3Rs, UK).
FMP Y‑maze
The FMP Y-maze has been previously shown to be a use-
ful method for assessing working memory, behavioral 
flexibility, and locomotion, and has been described in 
detail elsewhere (Cleal et al. 2020; Cleal and Parker 2018; 
Fontana et al. 2019). Briefly, fish were placed individually 
in white acrylic maze inserts (arms: L50 × W20 × D140 
mm). Each arm of the maze was set at 120° angles. There 
were two inserts per tank, allowing two individuals to 
be tested simultaneously. The inserts were fitted into a 
tank containing 3L of aquarium water (Fig. 1). The FMP 
Y-maze comes as a standard protocol within the commer-
cially available automated behavioral tracking unit (Zantiks 
AD system for adult zebrafish, Zantiks Ltd, Cambridge, 
UK). Fish were free to explore all arms of the maze for 
1 h (h). Entries and exits from each arm were automati-
cally recorded and logged in an excel file for the duration 
of the task. Arm entry data was extrapolated to obtain a 
time series of left and right turns, which were subsequently 
divided into 16 overlapping sequences of tetragrams (four 
consecutive turn choices, e.g. left, left, right, right [LLRR] 
or right, left, right, left [RLRL]; for details of analysis of 
tetragrams, see the “Data analysis” section below). Analy-
ses of temporal dynamics of search patterns have demon-
strated that zebrafish show flexibility in their behavior dur-
ing the search parameters. Pharmacological analyses have 
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demonstrated that alternations (LRLR, RLRL) are reduced 
by memory-blocking drugs in zebrafish (Cleal et al. 2020), 
suggesting that alternations are linked to working mem-
ory. Locomotion was measured by the total number of arm 
entries.
Experimental design
First, all fish were screened for baseline performance in the 
FMP Y-maze for 1 h of free exploration. Zebrafish were 
then allocated randomly into treatment groups (n = 12 
AMPH [25 µM]; n = 12 NIC [5 µM]; n = 12 control) and 
pair-housed in treatment groups for identification purposes. 
Experimenters were blinded to treatment-group allocation. 
We pair-housed the fish 4 days prior to the start of repeated 
intermittent exposure to drugs in order to ensure they had 
habituated to the new housing system, and during this 
time, technical staff were blinded to treatment allocation. 
Acquisition of AMPH or NIC sensitization was established 
over three treatment phases (Fig. 2). Phase I: each fish was 
given 14 consecutive 30-min daily sensitizing exposures to 
their respective treatment. On day 14, following their final 
30-min exposure, fish were immediately placed into the 
FMP Y-maze for 1 h of free exploration. Phase II: zebrafish 
had 2 days without treatment wherein they remained in 
their home tanks, in pair-housed conditions. After 48 h of 
withdrawal, zebrafish were recorded in the FMP Y-maze for 
1 h. Phase III: each group received a challenge dose of their 
Fig. 1  Schematic showing 
dimensions of individual 
Y-mazes (left), two Y-maze 
inserts (middle), and two 
Y-mazes inserted into a water-
tight tank (right). One zebrafish 
per Y-maze
Fig. 2  Schematic representation of working memory, cognitive flex-
ibility, and locomotor assessments during pre-treatment phase to 
establish baseline performance, following 14 days of daily drug treat-
ment (intermittent exposure), after 2  days of rest (withdrawal) and 






respective treatment for 30 min. Immediately following drug 
challenge, zebrafish were recorded in the FMP Y-maze for 
1 h.
Data analysis
All analyses were carried out using IBM SPSS Statis-
tics (v26) and graphical representations were completed 
using GraphPad Prism (v8). Studentized residuals were 
generated from statistical models and screened for out-
liers. Any data point identified as an extreme value 
(> 3*IQR) was removed from further analysis. Previous 
work from our lab has identified two regular tetragram 
patterns (alternations [LRLR + RLRL] and repetitions 
[RRRR + LLLL]) that appear disproportionately regu-
larly (compared to other sequences) throughout the dura-
tion of the trial. In order to study locomotor responses, 
we analysed each treatment stage based on the total num-
ber of turns completed during 1 h of exploration in the 
maze. LMM analysis was carried with “total turns” as the 
dependent variable, “treatment (AMPH, NIC, control)” 
and “treatment stage” (baseline, sensitizing, withdrawal, 
challenge) as the within-subjects factor, and “ID” as a 
random effect. Analysis was followed by the Bonferroni-
corrected post hoc test comparing each stage to baseline.
Cognitive flexibility was based on changes in alter-
nation strategy during trial progression. The percentage 
of alternations used during each 10-min time bin for 
six successive time bins was analysed using LMM with 
“alternations” as the dependent variable, “time” (6 lev-
els, 10-min time bins), “treatment” and “treatment stage” 
as the within-subjects factors, “total turns” as a covari-
ate, and “ID” as a random effect. Analysis was followed 
by the Bonferroni-corrected post hoc analysis comparing 
each time bin to every other time bin for each treatment 
group. Data are represented as mean + standard error of 
the mean for bar charts and mean ± SEM for scatter plots. 
Alpha values of p ≤ 0.05 were considered statistically 
significant.
Results
Development of sensitizing effects of AMPH and NIC 
on working memory and stereotypic behavior 
in adult zebrafish
Use of alternation strategy in the FMP Y-maze has 
been linked with changes in working memory. Adult 
zebrafish were assessed at pre-treatment stage, prior 
to drug exposure and then subsequently after 14-day 
intermittent exposure, withdrawal, and finally, follow-
ing drug challenge, to assess sensitization effects in 
water-treated (n = 12), AMPH-treated (n = 12), and NIC-
treated (n = 12) adult zebrafish. LMM showed a signifi-
cant effect of treatment stage (F3, 683 = 10.23, p < 0.001) 
and a significant treatment × treatment stage interaction 
(F3, 684 = 6.84, p < 0.01). There was no effect of treat-
ment alone (F2, 30 = 1.16, p = 0.33). Control fish treated 
with water showed no difference in alternation use 
between any treatment stage (p = 0.12). AMPH-treated 
fish demonstrated a significant effect of treatment stage 
with increased alternations after sensitization (95% CI, 
12.24–30.60, p < 0.001), returning to near baseline levels 
after withdrawal (although this effect fell short of signifi-
cance: 95% CI, − 0.141 to 16.75, p = 0.06). Drug chal-
lenge with AMPH caused alternation levels to increase 
significantly above baseline level (95% CI, 18.87–37.48, 
p < 0.001), demonstrating an increase in alternation use 
by ~ 11% after sensitization and ~ 19% following acute 
drug exposure. NIC has a significant effect on treatment 
stage (p = 0.03). Similarly to AMPH, NIC-treated fish 
showed no difference between sensitization and baseline 
(95% CI, − 0.814 to 16.45, p = 0.09) or withdrawal and 
baseline (95% CI, − 1.98 to 14.46, p = 0.21) alternation 
levels, but demonstrated a significant increase in alterna-
tions from ~ 25% at baseline to ~ 36% following sensitiza-
tion (95% CI, 1.889–20.376, p = 0.01) compared to pre-
treatment levels (Fig. 3A). Neither controls (p = 0.92) nor 
NIC-treated fish (p = 0.29) showed changes in repetition 
use at any treatment stage; however, AMPH-treated fish 
showed a significant effect of repetitions on treatment 
stage following drug challenge compared to baseline 
(95% CI, − 10.64 to − 2.67, p < 0.001) (Fig. 3B).
Fig. 3  Behavioral response to repeat drug exposure in adult zebrafish 
treated with NIC or AMPH. Analysis of drug-induced sensitization 
of AMPH- and NIC-induced cognitive enhancement. Working mem-
ory and stereotypic behavior were determined during several stages 
of drug exposure using a repeated measure analysis of pre-treatment 
(baseline) abilities compared to cognition following 14 days of sen-
sitization to either water (control/control), AMPH (AMPH/AMPH), 
or NIC (NIC/NIC), 2  days of withdrawal and after challenge with 
either water, AMPH, or NIC (n = 11 control, n = 11 AMPH, n = 12 
NIC treated). All animals were given an acute dose of the same treat-
ment that they were sensitized to. Data are expressed as mean + SEM 
of total percentage use of (A) alternations for assessment of work-
ing memory, (B) repetitions for the assessment of stereotypic behav-
ior and mean ± SEM of (C) locomotor activity based on total turns 
completed during 1  h of exploration. Data were analysed using a 
LMM analysis followed by the Bonferroni post hoc analysis compar-
ing each stage to baseline. (D) Analysis of total locomotor activity 
after repeated administration of water, AMPH, or NIC. Analysis of 
percentage use of alternations over time for each treatment stage per 
treatment group was analysed using LMM followed by the Bonferroni 
post hoc analysis using pairwise comparison of each 10-min time bin 
for a total of 6 time bins for (E) controls treated with water, (F) condi-
tioned to AMPH followed by acute AMPH challenge, and (G) condi-
tioned to NIC followed by acute NIC challenge. Data are expressed as 




Locomotor sensitization induced by AMPH and NIC
Locomotor activity was assessed by number of turns 
completed during 1  h of exploration. LMM revealed 
a significant effect on locomotor activity of treatment 
(F2, 122 = 4.47, p = 0.01) and treatment × treatment stage 
interaction (F3, 122 = 4.0, p < 0.01), but no main effect of 
treatment stage (F3, 122 = 1.15, p = 0.33). NIC demonstrated 
psychomotor sensitization following acute NIC challenge, 
resulting in hyperlocomotion compared to baseline (95% 
CI, − 4.41 to 16.13, p = 0.03) (Fig. 3C), while AMPH chal-
lenge caused significant hypolocomotion compared to con-
trols (95% CI, 99.99–539.8, p < 0.001) (Fig. 3D).
AMPH treatment inhibits cognitive flexibility
To assess cognitive flexibility, the percentage use of alterna-
tions was analysed as a factor of time. For each treatment 
group, LMM was used to examine the effect of treatment 
stage on alternations per time bin for six successive 10-min 
time bins. For controls, there was a significant effect on alter-
nations of time (F5, 208 = 4.06, p < 0.01), but no main effect 
of treatment stage (F3, 210 = 2.12, p = 0.10), or treatment 
stage × time interaction (F5, 208 = 0.55, p = 0.91) (Fig. 3E). 
NIC caused a significant effect on alternations of time 
(F5, 222 = 7.01, p < 0.01) of treatment stage (F3, 223.7 = 2.70, 
p = 0.05), but no effect of treatment stage × time interac-
tion (F5, 222 = 0.70, p = 0.79) (Fig. 3G). AMPH-treated fish 
showed a significant effect on alternations of treatment 
stage (F3, 191 = 20.91, p < 0.001), but no effects of time 
(F5, 190 = 1.42, p = 0.22) or a treatment stage × time interac-
tion (F5, 190 = 1.35, p = 0.18). Collectively, this demonstrated 
a significant impairment to alter use of alternations over time 
in fish treated with AMPH (Fig. 3F).
Discussion
Here, we investigated the sensitizing effects of the psy-
chostimulants AMPH and NIC on both cognitive abilities 
and locomotor responses in zebrafish. Psychostimulants 
have performance-enhancing effects, best characterized in 
subjects with low baseline levels of cognitive abilities or 
pre-existing disorders that cause cognitive deficits, such 
as schizophrenia or attention deficit hyperactivity disorder 
(ADHD) (for reviews, see Valentine and Sofuoglu 2017; 
Wood et al. 2014). AMPH is therefore the front-line phar-
maceutical treatment for ADHD, with many studies report-
ing improvements in attention and concentration (Faraone 
and Biederman 2002; James et al. 2001; Spencer et al. 
2006). Nicotine has similarly been found to ameliorate 
cognitive impairment in ADHD (Levin et al. 1996, 2006; 
Liebrenz et al. 2014; Rezvani and Levin 2001; Wilens 
2003). Although less conclusive, improvement in certain 
cognitive domains has also been reported in healthy sub-
jects treated with nicotine or “clinically relevant” doses of 
AMPH (Bagot and Kaminer 2014; Barch and Carter 2005; 
Heishman et al. 2010; Jasinska et al. 2014; Mattay et al. 
2000; Turner et al. 2003; Valentine and Sofuoglu 2017; 
Wood and Anagnostaras 2009). Here, we demonstrate 
that administering a moderate dose of AMPH, but not 
NIC, directly into the water of healthy adult zebrafish, for 
14 days of intermittent, daily exposure, improved working 
memory compared to baseline levels. In addition, unlike 
AMPH, NIC did not cause degradation of cognitive flex-
ibility, suggesting that it might have fewer unwanted nega-
tive effects compared to AMPH.
Repeat administration of psychostimulants induces 
behavioral sensitization when exposed to a subsequent 
drug challenge, and this often manifests as an enhance-
ment of cognitive function (Berridge et  al. 2012). Fol-
lowing repeated intermittent exposure, both AMPH- and 
NIC-treated adults showed cognitive sensitization, as evi-
denced by enhancement of performance, with alternation 
use increasing by ~ 11% for AMPH and ~ 8% for NIC (com-
pared to baseline) immediately following chronic dosing. A 
further increase of ~ 8% and ~ 3%, respectively, was reported 
following the challenge dose. Decreased alternations in the 
FMP Y-maze have been pharmacologically characterized as 
a reduction of working memory, suggesting that increased 
alternations may be indicative of improved working memory 
(Cleal et al. 2020). The sensitization of certain cognitive 
domains, such as working memory, is likely due to altered 
neurotransmission in ascending DA pathways from the stria-
tum (Berke and Hyman 2000). Previous studies have shown 
that after chronic administration of a psychostimulant, sub-
sequent doses cause increased DA release (Herman and Rob-
erto 2015). The duration of this increased DA response can 
be several weeks or, as demonstrated here, can be evoked 
after 48 h of withdrawal from sensitization treatment.
AMPH and NIC increase striatal DA release (Krause 
et al. 2002), which can enhance striatum-dependent tasks, 
such as those requiring working memory and memory con-
solidation (Brown et al. 2000; Landau et al. 2009), and 
subsequently potentiate performance of a previously estab-
lished pattern of behaviors, in this case, the increased use 
of alternations. Elevated striatal DA increases the use of 
“habits”, blocking the extinction of established behaviors 
following devaluation of the goal (Berke and Hyman 2000). 
This may provide a possible mechanism for the persistent 
use of alternations, at the expense of other strategies, after 
AMPH-induced sensitization. This response strategy may 
also represent persistent behavioral changes that are associ-
ated with drug addiction, in which the persistent seeking and 
taking of drugs of abuse come at the expense of other nor-
mal and necessary behaviors. The fact that this habitual use 
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of alternations, in favour of other search strategies, is only 
evident in AMPH-treated fish could be suggestive of the dif-
ferent mechanisms of increasing extracellular DA through 
dopaminergic or cholinergic pathways. Alternatively, the 
differences we observed between AMPH and NIC could be 
a result of the concentration used, and thus future studies 
should examine the sensitizing effects of a range of drug 
concentrations.
Psychomotor stimulants are known for their motor activ-
ity–altering effects (Cunningham et al. 1997). Repeated, 
intermittent exposure to psychostimulants causes progres-
sive enhancement of locomotor activity with subsequent 
challenge exposures (Adriani et al. 2006; Kuczenski and 
Segal 2002; Peleg-Raibstein et al. 2009; Pisera-Fuster et al. 
2019). Here, NIC treatment caused sensitized hyperloco-
motion, whereas AMPH-treated fish demonstrated hypolo-
comotion. Treatment with AMPH has been reported to 
have a paradoxical effect of cognitive enhancing attentional 
increases and behavioral-calming reductions of hyperac-
tivity. Many studies have shown that these effects are evi-
dent not only in patients diagnosed with ADHD but also 
in healthy subjects (Bagot and Kaminer 2014; Holze et al. 
2020; Roberts et al. 2020). Human studies with healthy par-
ticipants have shown that dosing with AMPH can cause an 
overall decrease in activity levels in healthy boys and adults 
and similar decreases in hyperactive boys. At low–moderate 
concentrations of AMPH (as used here), increased hypoac-
tivity is correlated with improved memory performance in 
cognitive tasks (Rapoport et al. 1980; Spencer et al. 2015). 
Here, we demonstrate improved cognitive performance cor-
responding to hypolocomotion in zebrafish.
NIC has regularly been reported as causing hyperlocomo-
tion. Progressive long-lasting increases in locomotor and 
DA-activating effects are generally associated with mod-
erate exposure regimens, whereas high doses of NIC for 
prolonged periods are more closely associated with signs 
of withdrawal and typically do not demonstrate locomotor 
sensitization (Pisera-Fuster et al. 2019). Several studies have 
shown that a single low dose of NIC is ineffective at induc-
ing locomotor or dopaminergic activation; however, daily 
low doses can induce locomotor sensitization after days of 
withdrawal from drug treatment (Fennell et al. 2020; Pisera-
Fuster et al. 2019). These conclusions are in line with our 
findings here, demonstrating no differences in locomotor 
effects following intermittent dosing; however, after just 
2 days of withdrawal, drug challenge resulted in psychomo-
tor sensitization, demonstrated by a significant rise in motor 
activity from baseline to repeat drug challenge.
The goal of exploring the FMP Y-maze could be per-
ceived as information seeking or foraging behavior. As fish 
become familiar with and continue to explore the test arena, 
they are continuously updating their knowledge of the envi-
ronment and this can subsequently be used to alter search 
strategies. In the FMP Y-maze, the absence of reward dur-
ing the 1 h of exploration has been shown to instigate a 
change in alternation use in healthy adult zebrafish. Many 
studies have investigated the relationship between DA ago-
nists, such as AMPH and methylphenidate (MPH), and the 
relationship between different cognitive domains such as 
working memory, attention, and cognitive flexibility (Bagot 
and Kaminer 2014). The inverted U–shaped response to psy-
chostimulants has often been reported to result in the simul-
taneous enhancement and impairment of multiple cognitive 
functions (Wood et al. 2014). Studies investigating effects 
of psychostimulants on cognitive function have reported that 
high levels of sustained attention correlate with lowered lev-
els of cognitive flexibility, assessed using set shifting tasks 
(Berridge et al. 2012).
The PFC has been found to be a key region for the regu-
lation of cognitive flexibility (Rougier et al. 2005). Both 
high prefrontal D1 receptor stimulation and low prefron-
tal D1 receptor stimulation have been linked with impaired 
flexibility responding in humans, using the Wisconsin Card 
Sorting Task (WCST) (Klanker et al. 2013; Takahashi et al. 
2008, 2012). In a previous study conducted by our lab, we 
administered a serial dilution of acute doses of the D1-like 
antagonist SCH-23390 prior to testing in the FMP Y-maze. 
We found that SCH-23390 severely impaired cognitive flex-
ibility in the FMP Y-maze at the highest dose (1.5 mg/L), but 
not at the lower doses (0.5–1.0 mg/L) which still maintained 
an effect of time on alternations. Additionally, all doses of 
SCH-23390 caused a significant reduction in overall use 
of alternations, hypolocomotion, and, at the highest dose, 
an increase in stereotypic behavior, shown by a significant 
increase in repetitions (Cleal et al. 2020). These findings, 
in conjunction with the present work, demonstrate a com-
plex role for D1 in modulating cognitive flexibility. Further 
work is required to disentangle the relationship between DA 
receptor activation and extracellular levels of DA to fully 
understanding the mechanisms involved in maintaining cog-
nitive flexibility and other cognitive functions.
Conclusion
We investigated the sensitizing effects of AMPH and NIC 
on working memory, locomotion, and cognitive flexibil-
ity. We demonstrated that non-contingent exposure to the 
psychostimulant AMPH, but not NIC, improved working 
memory performance in the FMP Y-maze after 14 days of 
intermittent dosing, returning to basal levels after 2 days 
of abstinence. Subsequent challenge resulted in sensitiza-
tion of both drugs, resulting in greater use of alternations, 
demonstrating an increase in the preference for this explora-
tion strategy. In AMPH, this increase in alternation use was 
accompanied by a decrease in the use of other strategies, 
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demonstrating a focused increase, bordering on stereotypic 
behavior. Only NIC demonstrated increased locomotor sen-
sitization compared to pre-drug exposure levels. AMPH 
caused significant hypolocomotion during challenge. Addi-
tionally, our findings suggest a role for dopaminergic, but 
not cholinergic, overactivation in the inhibition of cogni-
tive flexibility. Although the protocol for psychostimulant-
induced motor sensitization is substantially less cumbersome 
to establish than other models of addiction, it is not a precise 
homologue for psychostimulant addiction in humans (Berke 
and Hyman 2000). Understanding drug-induced changes in 
neurotransmitter systems and neural plasticity by studying 
cognitive sensitization may provide a useful model with 
high face validity. These results demonstrate that previous 
exposure of fish to AMPH or NIC can enhance cognitive 
performance, but this may come at a cost, with improved 
performance in one cognitive domain potentially resulting 
in disruption in another domain. This may demonstrate the 
first signs of drug-induced maladaptive activities. The dis-
tinction between cognitive enhancement and inhibition of 
normal behaviors may be dependent on cognitive flexibility, 
the loss of which has been strongly linked with substance 
abuse disorders which are often characterized by deficits 
in cognitive flexibility and may underlie the persistence of 
harmful, drug seeking and taking behaviors.
Finally, this paper is the first to demonstrate robust 
test–retest reliability for the FMP Y-maze. In previous stud-
ies, we have only looked at single exposures of animals to 
the maze. Our control animals showed no significant changes 
in total turns, alternations, repetitions, or general search pat-
terns in the maze between their four test periods, suggesting 
that the FMP Y-maze can be used longitudinally to examine 
changes in memory or behavioral flexibility over time.
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